INS and metabolic syndrome: Furthermore, associations of fat cell size with comorbidities of obesity (Type 2 diabetes (T2D), dyslipidemia, and cardiovascular disease) have been reported and insulin-resistant individuals were found to exhibit larger visceral adipocytes compared to insulin-sensitive controls [16–20].